Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Oramed Pharma (ORMP)

Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oramed Pharma 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 USA

www.oramed.com Employees: 15 P: 844-967-2633

Description:

Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel.

Key Statistics

Overview:

Market Capitalization, $K 94,330
Enterprise Value, $K 85,270
Shares Outstanding, K 40,312
Annual Sales, $ 1,340 K
Annual Net Income, $ 5,530 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -19,620 K
EBIT, $ -13,070 K
EBITDA, $ -12,870 K
60-Month Beta 1.77
% of Insider Shareholders 13.70%
% of Institutional Shareholders 12.73%
Float, K 34,789
% Float 86.30%
Short Volume Ratio 0.08

Growth:

1-Year Return 9.86%
3-Year Return -88.42%
5-Year Return -46.94%
5-Year Revenue Growth -50.37%
5-Year Earnings Growth 68.60%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.22 on 08/14/24
Next Earnings Date 11/28/24 [--]
Earnings Per Share ttm 0.18
EPS Growth vs. Prev Qtr 450.00%
EPS Growth vs. Prev Year 833.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 01/23/13

ORMP Ratios

Ratio
Price/Earnings ttm 23.10
Price/Earnings forward 9.62
Price/Earnings to Growth N/A
Return-on-Equity % -7.28%
Return-on-Assets % -6.22%
Profit Margin % 412.69%
Debt/Equity 0.00
Price/Sales 69.49
Price/Cash Flow N/A
Price/Book 0.61
Book Value/Share 3.81
Interest Coverage 3.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar